Skip to main content
. 2008 Mar 14;85(3):309–322. doi: 10.1007/s11524-008-9271-1

TABLE 4.

Injecting risk behaviors in the past 30 days among drug injectors in Newark, NJ and New York City, by city of recruitment, 2004–2006

  Total, N (%) Newark, N (%) NYC, N (%) OR (95% CI) AOR (95% CI)a p value
Total 526 (100) 214 (40.7) 312 (59.3)
Injected with a used syringe from another injector
 No 460 (87.5) 173 (80.8) 287 (92.0) 2.72 (1.60–4.63) 2.32 (1.07–5.04) 0.0337
 Yes 66 (12.5) 41 (19.2) 25 (8.0)
Reused own syringe
 No 403 (76.6) 133 (62.1) 270 (86.5) 3.91 (2.56–6.00) 2.99 (1.63–5.50) 0.0004
 Yes 123 (23.4) 81 (37.9) 42 (13.5)
Did not always inject once only with a new, sterile syringe that had been sealed in a wrapper
 No 147 (27.9) 22 (10.3) 125 (40.1) 5.79 (3.52–9.50) 5.43 (2.86–10.30) <0.0001
 Yes 379 (72.1) 192 (89.7) 187 (59.9)
Receptive syringe Sharing
 No 398 (75.7) 150 (70.1) 248 (79.5) 1.65 (1.11–2.47) 1.54 (0.86–2.79) 0.1497
 Yes 128 (24.3) 64 (29.9) 64 (20.5)
Distributive syringe sharing
 No 386 (73.4) 149 (69.6) 237 (76.0) 1.38 (0.93–2.04) 1.64 (0.91–2.94) 0.0973
 Yes 140 (26.6) 65 (30.4) 75 (24.0)
Shared cooker/filter/rinse water
 No 318 (60.5) 121 (56.5) 197 (63.1) 1.32 (0.92–1.88) 1.08 (0.65–1.82) 0.7590
 Yes 208 (39.5) 93 (43.5) 115 (36.9)
Receptive syringe-mediated drug sharing
 No 436(82.9) 168 (78.5) 268 (85.9) 1.67 (1.06–2.63) 1.43 (0.73–2.81) 0.2980
 Yes 90 (17.1) 46 (21.5) 44 (14.1)
Distributive syringe-mediated drug sharing
 No 442 (84.0) 175 (81.8) 267 (85.6) 1.32 (0.83–2.11) 1.07 (0.53–2.17) 0.8376
 Yes 84 (16.0) 39 (18.2) 45 (14.4)

aAOR adjusted by age, race/ethnicity, income, years since initiated injecting, currently in drug dependence treatment, number of times injected in past 30 days, injected heroin in past 30 days, injected speedball in past 30 days, used noninjection cocaine in past 30 days, the most frequent injecting location is participant’s own residence, and self-reported being HIV infected